Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46.
about
Early-life exposures to infectious agents and later cancer developmentHuman monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopesImmunogenic and Functional Organization of Hepatitis C Virus (HCV) Glycoprotein E2 on Infectious HCV VirionsRNA stability regulates human T cell leukemia virus type 1 gene expression in chronically-infected CD4 T cells.The humoral immune response to human T-cell lymphotropic virus type 1 envelope glycoprotein gp46 is directed primarily against conformational epitopes.Amino acid changes at positions 173 and 187 in the human T-cell leukemia virus type 1 surface glycoprotein induce specific neutralizing antibodies.Similar regulation of cell surface human T-cell leukemia virus type 1 (HTLV-1) surface binding proteins in cells highly and poorly transduced by HTLV-1-pseudotyped virionsHuman monoclonal antibody to hepatitis C virus E1 glycoprotein that blocks virus attachment and viral infectivityConformation-specific antibodies targeting the trimer-of-hairpins motif of the human T-cell leukemia virus type 1 transmembrane glycoprotein recognize the viral envelope but fail to neutralize viral entryDC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells.Population-based Seroprevalence of HTLV-I Infection in Golestan Province, South East of Caspian Sea, Iran.Highly specific inhibition of leukaemia virus membrane fusion by interaction of peptide antagonists with a conserved region of the coiled coil of envelope.Pseudotyping of HIV-1 with Human T-Lymphotropic Virus 1 (HTLV-1) Envelope Glycoprotein during HIV-1-HTLV-1 Coinfection Facilitates Direct HIV-1 Infection of Female Genital Epithelial Cells: Implications for Sexual Transmission of HIV-1.
P2860
Q26786103-81FBC431-7EE9-4EB3-8F62-7E6C216B344DQ27469599-30ED31A2-2DDA-4A29-92C9-26224C589642Q27478035-D16184CF-630F-4E85-9F39-6783E953781BQ30252424-8EEE6B56-A5FA-42A3-A6E9-F5C8F2EB9A5AQ33640882-58309CCA-CA36-484B-B997-88686D46B6FFQ33823227-353BF251-D306-4BC5-ADEB-FFAC03082733Q34354324-5838484C-26CE-4182-8A63-51B7671B2A3EQ34437763-B4D9BD92-A36D-4E9B-8DD3-20F1E6EEAB91Q35857748-E0A90A39-44E6-43CC-B345-6E13738DF5EFQ37410819-BE413FC6-E1A0-47A6-9A3A-E310449FE515Q37435364-22E37F70-A5E3-4BD2-8D38-115D034EBEBDQ41834173-136D2C63-9176-423E-9FFE-6B026DC08183Q53695196-B1E9CC1A-9714-4613-BA68-8405F5C7D4A4
P2860
Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Neutralizing human monoclonal ...... ropic virus type 1 and 2 gp46.
@en
Neutralizing human monoclonal ...... ropic virus type 1 and 2 gp46.
@nl
type
label
Neutralizing human monoclonal ...... ropic virus type 1 and 2 gp46.
@en
Neutralizing human monoclonal ...... ropic virus type 1 and 2 gp46.
@nl
prefLabel
Neutralizing human monoclonal ...... ropic virus type 1 and 2 gp46.
@en
Neutralizing human monoclonal ...... ropic virus type 1 and 2 gp46.
@nl
P2093
P2860
P1433
P1476
Neutralizing human monoclonal ...... tropic virus type 1 and 2 gp46
@en
P2093
K G Hadlock
M S McGrath
P Bradshaw
P2860
P304
P407
P577
1997-08-01T00:00:00Z